Annual Long Term Debt
$1.40 M
-$260.50 K-15.72%
December 1, 2023
Summary
- As of February 6, 2025, CSCI annual long term debt is $1.40 million, with the most recent change of -$260.50 thousand (-15.72%) on December 1, 2023.
- During the last 3 years, CSCI annual long term debt has fallen by -$681.00 thousand (-32.78%).
- CSCI annual long term debt is now -62.48% below its all-time high of $3.72 million, reached on December 1, 1996.
Performance
CSCI Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$1.21 M
-$69.00 K-5.39%
September 1, 2024
Summary
- As of February 6, 2025, CSCI quarterly long term debt is $1.21 million, with the most recent change of -$69.00 thousand (-5.39%) on September 1, 2024.
- Over the past year, CSCI quarterly long term debt has dropped by -$185.30 thousand (-13.27%).
- CSCI quarterly long term debt is now -69.05% below its all-time high of $3.91 million, reached on March 1, 1997.
Performance
CSCI Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
CSCI Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.7% | -13.3% |
| 3 y3 years | -32.8% | -13.3% |
| 5 y5 years | +743.2% | -13.3% |
CSCI Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -24.5% | at low | -34.5% | at low |
| 5 y | 5-year | -35.7% | at low | -44.2% | at low |
| alltime | all time | -62.5% | +8018.0% | -69.0% | >+9999.0% |
COSCIENS Biopharma Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.21 M(-5.4%) |
| Jun 2024 | - | $1.28 M(-1.2%) |
| Mar 2024 | - | $1.30 M(-7.2%) |
| Dec 2023 | $1.40 M(-15.7%) | $1.40 M(-2.8%) |
| Sep 2023 | - | $1.44 M(-7.2%) |
| Jun 2023 | - | $1.55 M(-2.6%) |
| Mar 2023 | - | $1.59 M(-4.0%) |
| Dec 2022 | $1.66 M(-10.4%) | $1.66 M(+6.9%) |
| Sep 2022 | - | $1.55 M(-9.3%) |
| Jun 2022 | - | $1.71 M(-6.6%) |
| Mar 2022 | - | $1.83 M(-1.1%) |
| Dec 2021 | $1.85 M(-10.9%) | $1.85 M(-3.0%) |
| Sep 2021 | - | $1.91 M(-5.6%) |
| Jun 2021 | - | $2.02 M(-1.0%) |
| Mar 2021 | - | $2.04 M(-1.7%) |
| Dec 2020 | $2.08 M(-4.4%) | $2.08 M(+5.4%) |
| Sep 2020 | - | $1.97 M(-0.5%) |
| Jun 2020 | - | $1.98 M(+1.4%) |
| Mar 2020 | - | $1.95 M(-10.0%) |
| Dec 2019 | $2.17 M(+1211.6%) | $2.17 M(-3.3%) |
| Sep 2019 | - | $2.25 M(-3.4%) |
| Jun 2019 | - | $2.32 M(-1.8%) |
| Mar 2019 | - | $2.37 M(+1329.0%) |
| Dec 2018 | $165.60 K(-64.8%) | $165.60 K(-36.3%) |
| Sep 2018 | - | $259.90 K(-8.3%) |
| Jun 2018 | - | $283.40 K(-17.1%) |
| Mar 2018 | - | $341.80 K(-27.4%) |
| Dec 2017 | $470.80 K(-56.6%) | $470.80 K(-32.3%) |
| Sep 2017 | - | $695.80 K(+3.2%) |
| Jun 2017 | - | $674.10 K(-27.9%) |
| Mar 2017 | - | $935.60 K(-13.7%) |
| Dec 2016 | $1.08 M(-40.1%) | $1.08 M(-20.2%) |
| Sep 2016 | - | $1.36 M(-12.7%) |
| Jun 2016 | - | $1.56 M(-10.8%) |
| Mar 2016 | - | $1.74 M(-3.6%) |
| Dec 2015 | $1.81 M(-20.0%) | $1.81 M(-33.7%) |
| Sep 2015 | - | $2.73 M(-7.6%) |
| Jun 2015 | - | $2.96 M(+7.7%) |
| Mar 2015 | - | $2.75 M(+21.4%) |
| Dec 2014 | $2.26 M(-4.1%) | $2.26 M(-12.8%) |
| Sep 2014 | - | $2.59 M(-11.7%) |
| Jun 2014 | - | $2.94 M(+25.1%) |
| Mar 2014 | - | $2.35 M(-0.4%) |
| Dec 2013 | $2.36 M(+209.8%) | $2.36 M(+288.3%) |
| Sep 2013 | - | $607.80 K(-4.7%) |
| Jun 2013 | - | $637.70 K(-33.4%) |
| Mar 2013 | - | $958.00 K(+25.8%) |
| Dec 2012 | $761.80 K(-16.1%) | $761.80 K(+444.9%) |
| Sep 2012 | - | $139.80 K(+22.6%) |
| Jun 2012 | - | $114.00 K(-87.4%) |
| Dec 2011 | $907.50 K(-16.0%) | $907.50 K(-2.5%) |
| Sep 2011 | - | $930.80 K(-10.5%) |
| Jun 2011 | - | $1.04 M(-3.1%) |
| Mar 2011 | - | $1.07 M(-0.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2010 | $1.08 M(-32.1%) | $1.08 M(-29.9%) |
| Sep 2010 | - | $1.54 M(+0.9%) |
| Jun 2010 | - | $1.53 M(-5.0%) |
| Mar 2010 | - | $1.61 M(+1.0%) |
| Dec 2009 | $1.59 M(+40.4%) | $1.59 M(+36.0%) |
| Sep 2009 | - | $1.17 M(+4.8%) |
| Jun 2009 | - | $1.12 M(+5.9%) |
| Mar 2009 | - | $1.06 M(-7.0%) |
| Dec 2008 | $1.13 M(-25.1%) | $1.13 M(-14.2%) |
| Sep 2008 | - | $1.32 M(-6.1%) |
| Jun 2008 | - | $1.41 M(-2.2%) |
| Mar 2008 | - | $1.44 M(-5.0%) |
| Dec 2007 | $1.51 M(+341.2%) | $1.51 M(+69.5%) |
| Sep 2007 | - | $893.40 K(+5.6%) |
| Jun 2007 | - | $846.20 K(+150.0%) |
| Mar 2007 | - | $338.50 K(-1.4%) |
| Dec 2006 | $343.30 K(-8.7%) | $343.30 K(-8.5%) |
| Sep 2006 | - | $375.10 K(-0.2%) |
| Jun 2006 | - | $375.90 K(+1.7%) |
| Mar 2006 | - | $369.60 K(-1.7%) |
| Dec 2005 | $376.00 K(-4.2%) | $376.00 K(-2.2%) |
| Sep 2005 | - | $384.40 K(+3.4%) |
| Jun 2005 | - | $371.70 K(-3.0%) |
| Mar 2005 | - | $383.30 K(-2.3%) |
| Dec 2004 | $392.40 K(+2181.4%) | $392.40 K(+161.1%) |
| Sep 2004 | - | $150.30 K(+94.7%) |
| Jun 2004 | - | $77.20 K(-22.4%) |
| Mar 2004 | - | $99.50 K(+478.5%) |
| Dec 2003 | $17.20 K(-95.4%) | $17.20 K(-86.2%) |
| Sep 2003 | - | $125.00 K(-58.4%) |
| Jun 2003 | - | $300.80 K(-17.3%) |
| Mar 2003 | - | $363.60 K(-3.5%) |
| Dec 2002 | $376.90 K(+1813.2%) | $376.90 K(+5698.5%) |
| Sep 2002 | - | $6500.00(-40.9%) |
| Jun 2002 | - | $11.00 K(-19.7%) |
| Mar 2002 | - | $13.70 K(-30.5%) |
| Dec 2001 | $19.70 K(-45.9%) | $19.70 K(-76.5%) |
| Sep 2001 | - | $83.90 K(+209.6%) |
| Jun 2001 | - | $27.10 K(-15.0%) |
| Mar 2001 | - | $31.90 K(-12.4%) |
| Dec 2000 | $36.40 K(-47.2%) | $36.40 K(-10.1%) |
| Sep 2000 | - | $40.50 K(-40.0%) |
| Jun 2000 | - | $67.50 K(-83.7%) |
| Mar 2000 | - | $413.10 K(+498.7%) |
| Dec 1999 | $69.00 K(-67.1%) | $69.00 K(+1.3%) |
| Sep 1999 | - | $68.10 K(+0.4%) |
| Jun 1999 | - | $67.80 K(+3.5%) |
| Sep 1998 | - | $65.50 K(-90.4%) |
| Jun 1998 | - | $680.70 K(-12.2%) |
| Mar 1998 | - | $774.90 K(+269.7%) |
| Dec 1997 | $209.60 K(-94.4%) | $209.60 K(-94.2%) |
| Sep 1997 | - | $3.62 M(-3.9%) |
| Jun 1997 | - | $3.77 M(-3.8%) |
| Mar 1997 | - | $3.91 M |
| Dec 1996 | $3.72 M | - |
FAQ
- What is COSCIENS Biopharma annual long term debt?
- What is the all time high annual long term debt for COSCIENS Biopharma?
- What is COSCIENS Biopharma annual long term debt year-on-year change?
- What is COSCIENS Biopharma quarterly long term debt?
- What is the all time high quarterly long term debt for COSCIENS Biopharma?
- What is COSCIENS Biopharma quarterly long term debt year-on-year change?
What is COSCIENS Biopharma annual long term debt?
The current annual long term debt of CSCI is $1.40 M
What is the all time high annual long term debt for COSCIENS Biopharma?
COSCIENS Biopharma all-time high annual long term debt is $3.72 M
What is COSCIENS Biopharma annual long term debt year-on-year change?
Over the past year, CSCI annual long term debt has changed by -$260.50 K (-15.72%)
What is COSCIENS Biopharma quarterly long term debt?
The current quarterly long term debt of CSCI is $1.21 M
What is the all time high quarterly long term debt for COSCIENS Biopharma?
COSCIENS Biopharma all-time high quarterly long term debt is $3.91 M
What is COSCIENS Biopharma quarterly long term debt year-on-year change?
Over the past year, CSCI quarterly long term debt has changed by -$185.30 K (-13.27%)